-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/behavioral-counseling-interventions-evidence-based-approach
March 04, 2021 - preferred outcome measures may not be widely available in the literature, because behavioral outcome definitions
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/quality-measures/qsrs/qsrs-2021-2022-adverse-event-data-report-oct-rev.pdf
January 01, 2022 - QSRS uses standardized definitions and algorithms consistent with the AHRQ
Common Formats for Surveillance.i
-
hcup-us.ahrq.gov/reports/methods/2003_04.pdf
January 01, 2003 - Population with income under the
poverty level
56%
*Calculated using Claritas and 1990 Census race definitions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - Definitions of effect sizes
Effect Size Definition
Small effect • MD 0.5 to 1.0 points on a 0 to 10
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Jz4WcZ2Wy3-nV6jNUrwUzX
June 20, 2017 - developed by the US Preventive Services Task Force for
randomized clinical trials; the criteria and definitions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
October 01, 2022 - Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review
Rapid Evidence Product
Nonemergent Percutaneous Coronary Intervention
Versus Optimal Medical Treatment for Stable Ischemic
Heart Disease: …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults
Making Healthcare Safer IV
Reducing Adverse Drug Events Related to
Anticoagulant Use in Adults
Rapid Response
Main Points
1. Anticoagulation medications help prevent life-threatening events such…
-
www.ahrq.gov/sites/default/files/publications/files/chipra-final-report_0.pdf
February 21, 2016 - National Evaluation of the CHIPRA Quality Demonstration Grant Program: Final Project Report
Contract Final Report
National Evaluation of the CHIPRA Quality
Demonstration Grant Program: Final Project Report
Prepared for:
Agency for Healthcare Research and Quality
Rockville, MD
Contract HHSA29020090002191
…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
August 20, 2019 - Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Updated Evidence Report and Systematic Review for the USPSTF
Risk Assessment, Genetic Counseling, and Genetic Testing
for BRCA-Related Cancer in Women
Updated Evidence Report and Systematic Review
for the US Preventive Services Task For…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TAgAUJ5QoaRfV3M8fApBoN
June 03, 2019 - Breast Cancer Screening: A Summary of the Evidence for the U.S.
Preventive Services Task Force
Linda L. Humphrey, MD, MPH; Mark Helfand, MD, MS; Benjamin K.S. Chan, MS; and Steven H. Woolf, MD, MPH
Purpose: To synthesize new data on breast cancer screening for
the U.S. Preventive Services Task Force.
Data Sources: ME…
-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/hisph-slides.html
March 01, 2020 - Note: For information on confidentiality protection, nonsampling error, and definitions, go to http … -Mexico Border
Definitions
Slide 174
Conditions of Interest
Cancers: Any Dx in CCS 24 (breast
-
www.ahrq.gov/sites/default/files/wysiwyg/npsd/data/npsd-chartbook-2021.pdf
January 01, 2021 - AHRQ developed the Common Formats, a standardized reporting format using common language
and definitions … provides a basis for comparing harm across the different event types in
CFER-H, it is noteworthy that the definitions
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary: Aspirin Use to Prevent Cardiovascular Events
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication
April 11, 2…
-
digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-transcript-081811.pdf
June 16, 2021 - MEDICATION MANAGEMENT USING HEALTH IT FOR THE CARE OF ELDERLY PATIENTS
______________________________________________________________________________________
Medication Management using Health IT for the Care of Elderly Patients Transcript.doc Page 1 of 20
TRANSCRIPT OF AUDIO FILE:
MEDICATION MANAGEME…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
January 01, 2015 - 1
Treatments for Fibromyalgia in Adult
Subgroups
Executive Summary
Background
Fibromyalgia is a chronic diffuse
musculoskeletal pain syndrome that has
no clearly identified etiology.1-4 It affects
mostly adults5 and is characterized by
chronic widespread pain, abnormal
processing of and heightened sensitivity …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Layout 1
Background
This report evaluates the level of evidence
currently available to support the
effectiveness and safety of using
recombinant activated coagulation factor
VII (rFVIIa) for clinical indications not
approved by the U. S. Food and Drug
Administration (FDA). rFVIIa is approved
for a variety of uses i…
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs017191-pohl-final-report-2011.pdf
January 01, 2011 - A Partnership for Clinician EHR Use and Quality of Care - Final Report
A Partnership for Clinician EHR Use and Quality of Care
Final Progress Report
Principal I nves…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023395-kent-final-report-2017.pdf
January 01, 2017 - Patient-Centered Postoperative Wound Surveillance Using Current Technology - Final Report
Project title: Patient-Centered Postoperative Wound Surveillance Using Current Technology
Principal Investigator: K. Craig Kent, MD
Team Members: Sara Fernandes-Taylor, PhD; Dai Yamanouchi, MD, Rebecca Gunter, MD
Organiza…
-
www.ahrq.gov/sites/default/files/2024-01/kennelty-report.pdf
January 01, 2024 - Final Progress Report: Medication List Consistency When Patients Transition from Hospital to Community
TITLE PAGE
Medication List Consistency When Patients Transition from Hospital to Community
Principal Investigator: Korey A. Kennelty
Team Mentors: Betty Chewning, Amy Kind, David Kreling,
Dave Mott, Beth Martin,…
-
www.ahrq.gov/sites/default/files/2024-01/feldman-report.pdf
January 01, 2024 - Final Progress Report: Improving Medication Management Practices and Care Transitions Through Technology
Improving Medication Management Practices and
Care Transitions through Technology
Penny H. Feldman, Ph.D. – Principal Investigator
Liliana E. Pezzin, Ph.D. – Co-Investigator
Timothy R. Peng, Ph.D. – Co-Inv…